Effective BK channel openers have been sought or explored to treat a variety of diseases such as stroke, epilepsy, psychoses, bladder overactivity, erectile dysfunction, asthma, arterial hypertension, ischemic heart disease, and gastric hypermotility (Nardi and Olesen, 2008). Here, KCNMA1 is linked to epilepsy.